Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim

Clin Mol Hepatol. 2021;27(3):402-412. Published online June 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0179

View: 6097 Download: 255 Web of Science: 32 Crossref: 30

Original Article

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response

Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn

Clin Mol Hepatol. 2020;26(3):352-363. Published online May 28, 2020

DOI: https://doi.org/10.3350/cmh.2019.0044n

View: 4938 Download: 185 Web of Science: 4 Crossref: 5

Editorial

Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?

Byoung Kuk Jang

Clin Mol Hepatol. 2020;26(3):312-314. Published online July 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0099

View: 5035 Download: 122 Crossref: 2

Original Article

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B

Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh

Clin Mol Hepatol. 2017;23(4):331-339. Published online September 26, 2017

DOI: https://doi.org/10.3350/cmh.2016.0040

View: 8146 Download: 216 Web of Science: 14 Crossref: 10

Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience

Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim

Clin Mol Hepatol. 2017;23(4):323-330. Published online September 5, 2017

DOI: https://doi.org/10.3350/cmh.2017.0005

View: 7420 Download: 179 Web of Science: 6 Crossref: 9

Editorial

Lamivudine: fading into the mists of time

Jonggi Choi, Young-Suk Lim

Clin Mol Hepatol. 2017;23(4):314-315. Published online November 28, 2017

DOI: https://doi.org/10.3350/cmh.2017.0110

View: 5648 Download: 124

Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?

Joon Yeul Nam, Jeong-Hoon Lee

Clin Mol Hepatol. 2017;23(4):311-313. Published online December 4, 2017

DOI: https://doi.org/10.3350/cmh.2017.0069

View: 6091 Download: 142

Original Article

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir

Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin

Clin Mol Hepatol. 2017;23(3):230-238. Published online June 30, 2017

DOI: https://doi.org/10.3350/cmh.2017.0003

View: 9515 Download: 165 Web of Science: 11 Crossref: 13

Editorial

Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?

Yun Bin Lee, Jeong-Hoon Lee

Clin Mol Hepatol. 2017;23(3):219-221. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0045

View: 7739 Download: 153 Web of Science: 1 Crossref: 2

Original Article

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment

Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi

Clin Mol Hepatol. 2016;22(3):350-358. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0019

View: 9015 Download: 138 Web of Science: 1 Crossref: 1

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon

Clin Mol Hepatol. 2016;22(2):241-249. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2015.0053

View: 9895 Download: 138 Web of Science: 4 Crossref: 4

Case Report

Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis

Hye Young Jwa, Yoo-Kyung Cho, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong, Bong Soo Kim, Byoung-Wook Lee, Byung-Cheol Song

Clin Mol Hepatol. 2016;22(1):183-187. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.183

View: 11701 Download: 148 Web of Science: 4 Crossref: 4

Original Article

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

Jung Gil Park, Soo Young Park

Clin Mol Hepatol. 2015;21(3):242-248. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.242

View: 8146 Download: 84 Web of Science: 5 Crossref: 3

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients

Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim

Clin Mol Hepatol. 2015;21(2):131-140. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.131

View: 7930 Download: 84 Web of Science: 2 Crossref: 2

Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir

Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim

Clin Mol Hepatol. 2015;21(1):24-31. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.24

View: 8797 Download: 109 Web of Science: 14 Crossref: 14

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir

EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee

Clin Mol Hepatol. 2014;20(3):267-273. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.267

View: 7923 Download: 71 Web of Science: 4 Crossref: 5

HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data

Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2013;19(4):409-416. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.409

View: 6302 Download: 61 Crossref: 6

Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B

Sang Hoon Ahn, Ji-Yong Chun, Soo-Kyung Shin, Jun Yong Park, Wangdon Yoo, Sun Pyo Hong, Soo-Ok Kim, Kwang-Hyub Han

Clin Mol Hepatol. 2013;19(4):399-408. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.399

View: 6841 Download: 49 Crossref: 2

Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study

Dae Won Jun, Byung Ik Kim, Yong Kyun Cho, Hong Ju Kim, Young Oh Kwon, Soo Young Park, Sang Young Han, Yang Hyun Baek, Yong Jin Jung, Hwi Young Kim, Won Kim, Jeong Heo, Hyun Young Woo, Seong Gyu Hwang, Kyu Sung Rim, Jong Young Choi, Si Hyun Bae, Young Sang Lee, Young Suck Lim, Jae Youn Cheong, Sung Won Cho, Byung Seok Lee, Seok Hyun Kim, Joo Hyun Sohn, Tae Yeob Kim, Yong Han Paik, Ja Kyung Kim, Kwan Sik Lee

Clin Mol Hepatol. 2013;19(2):165-172. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.165

View: 10610 Download: 154 Crossref: 22

Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B

Mi Sung Park, Beom Kyung Kim, Kyung Sik Kim, Ja Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Oidov Baartarkhuu, Kwang Hyub Han, Chae Yoon Chon, Sang Hoon Ahn

Clin Mol Hepatol. 2013;19(1):29-35. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.29

View: 7629 Download: 56 Crossref: 11

Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection

Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh

Clin Mol Hepatol. 2012;18(2):195-202. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.195

View: 9243 Download: 71 Crossref: 12

High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B

Hee Bok Chae, Mee Jin Kim, Eui Geun Seo, Yong Hyeok Choi, Hee Seung Lee, Joung Ho Han, Soon Man Yoon, Seon Mee Park, Sei Jin Youn

Clin Mol Hepatol. 2012;18(1):75-83. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.75

View: 7319 Download: 45 Crossref: 12

Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B

Joon Chang Song, Bo Young Min, Jin-Wook Kim, Jong Yeop Kim, Yeo Myeong Kim, Cheol Min Shin, Sang Hyub Lee, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee

Clin Mol Hepatol. 2011;17(4):268-273. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.268

View: 7541 Download: 64 Crossref: 8

3

Genotypic resistance to entecavir in chronic hepatitis B patients

Byeong Uk Kim, M.D., Ja Chung Goo, M.D., Byeong Chul Park, M.D., Soo Ok Kim, Ph.D. Sun Pyo Hong, Ph.D. Jee In Jeong, M.D., Hee Bok Chae, M.D., Seon Mee Park, M.D., Sei Jin Youn, M.D.

Clin Mol Hepatol. 2010;16(2):147-157. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.147

View: 5165 Download: 24 Crossref: 2

Efficacy and predictors of the virologic response to entecavir therapy in nucleoside naive patients with chronic hepatitis B

Hyung-Joon Myung, M.D., Sook-Hyang Jeong, M.D., Jin-Wook Kim, M.D., Hee-Sup Kim, M.D., Je-Hyuck Jang, M.D., Dong Ho Lee, M.D., Nayoung Kim, M.D., Jin-Hyeok Hwang, M.D., Young Soo Park, M.D., Sang-Hyub Lee, M.D.

Clin Mol Hepatol. 2010;16(1):57-65. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.57

View: 5400 Download: 31 Crossref: 9

Validity and reliability of the nonalcoholic fatty Liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors

Kyung-Hun Lee, M.D., Sang Hoon Park, M.D., Yu Jin Kim, M.D., Kyung Rim Huh, M.D., Kwang Seon Min M.D., Sun-Young Jun M.D., Kyoung Oh Kim, M.D., Cheol Hee Park, M.D., Taeho Hahn, M.D., Kyo-Sang Yoo, M.D., Jong Hyeok Kim, M.D., Myung-Seok Lee, M.D., Choong Kee Park, M.D.

Clin Mol Hepatol. 2010;16(1):29-37. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.29

View: 5116 Download: 54 Crossref: 2

1

Predictors for virologic response in management of chronic hepatitis B

Jung Min Lee, M.D. Sang Hoon Ahn, M.D.-

Clin Mol Hepatol. 2010;16(1):1-4. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.1

View: 4139 Download: 27

3

Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients

Myoung Hee Lee , Sun Gyo Lim , Su Jin Jeon , Chang Joon Kang , Young Ju Cho , Soon Sun Kim , Da Mi Lee , Jae Youn Cheong , Sung Won Cho

Clin Mol Hepatol. 2009;15(4):446-453. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.446

View: 4500 Download: 27 Crossref: 4

7

The Korean Journal of Entecavir 1 mg therapy for Lamivudine-refractory chronic hepatitis B

Hyung Joon Kim

Clin Mol Hepatol. 2008;14(3):411-416. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.411

View: 3981 Download: 15

Original Article

Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study

Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon

Received January 20, 2024 Accepted May 9, 2024

DOI: https://doi.org/10.3350/cmh.2024.0055 [Accepted]

View: 372 Download: 54

1 |

Viewed By 6392	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5321	MAFLD: How is it different from NAFLD?
Viewed By 5125	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4416	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4201	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 160	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 107	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 94	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 74	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 72	MAFLD: How is it different from NAFLD?

Search